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Methods: EPS was performed in 51 patients aged from 13 to 50 years
(mean 30±16) for a PS. Atrial stimulation was performed in control state (CS)
at a cycle length of 400ms and coupling was decereased until AP6RP or atrial
RP. Measurement was repeated after isoproterenol when AP-RP≥250ms in
CS. Measurement was performed by transesophageal route and then by intra-
cardiac route, with a delay not >3 months. 
Results: AP-RP’s were 267±50ms in CS, 233±49ms after isoproterenol at
transesophageal EPS, 309±72ms in CS, 280±64ms after isoproterenol at intra-
cardiac EPS (p<0.002). Among 31 patients with initially AP-RP ≥250ms at
transesophageal EPS, AP-RP was ≤220ms after isoproterenol in 12 patients.
All, but one had an AP-RP≥250ms in CS at intracardiac EPS; one patient with
AP-RP of 270ms at esophageal EPS had a value of 240ms at intracardiac EPS
in CS but value was 250ms after isoproterenol. Three patients with trans-
esophageal AP-RP in CS and after isoproterenol ≥280ms had lost their antero-
grade conduction. At transesophageal EPS, AP-RP was <250ms in 20 patients
of which only 8 had a short AP-RP at intracardiac EPS and 3 had a short AP-
RP after isoproterenol. There was no significant difference for the induction
of orthodromic tachycardia at transesophageal and intracardiac EPS (72%) and
there was a similar induction of atrial fibrillation at transesophageal EPS
(32%) and intracardiac EPS (28%).
Conclusions: A long AP refractory period measured at transesophageal
EPS excluded the presence of an AP with a short refractory period at intra-
cardiac study even after isoproterenol. There was an adrenergic factor during
transesophageal EPS and isoproterenol produced a significant shortening of
AP refractory periods in only 39% of patients with AP-RP ≥250ms. When
AP-RP is ≥280ms at transesophageal EPS, the loss of anterograde conduction
in AP can be expected in the following weeks (15%). 
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AV block following radiofrequency (RF) ablation for the treatment of
atrioventricular nodal reentrant tachycardia (AVNRT) is a rare but well reco-
gnised complication of the procedure. The purpose of the study was to report
the long-term follow-up of patients a first d (AVB1), second d (AVB2), or
third d A V block (AVB3) occurred during ablation of AVNRT.
Methods: 930 patients, 615 females, aged from 12 to 92 years, mean age
52±18, had AVNRT. RF energy, 65°, 40 watts was delivered on the slow
pathway, until AVNRT was not induced. 
Results: 94 patients presented a transitory or permanent AVB1,2,3. In 8,
mean age 53±21.5 years, AVB was of vagal origin generally occurring at
femoral puncture (group I). In 26 patients, mean age 46±21, it was traumatic
and regressive occurring either in young patients with a normal conduction
system or in 3 patients with a left bundle branch block. In remaining 60
patients, AVB was directly related to the RF application; AVB was of first
degree in 22 patients aged 56±17 years; it was of 2nd or third degree AVB in
38 patients: in 2 patients AVB3 remained permanent and in all other patients
it was partially or totally regressive. After a follow-up of 2.1±2 years, pace-
maker implantation was implanted in 15 patients, 1 patient with traumatic
AVB3 aged 81 years, 5 patients with AVB3 during ablation, 2 with permanent
AVB3 (0.2%) and 3 with transitory AVB3 and 9 patients without AVB during
ablation. In these last patients, 2 had spontaneous long HV interval. Age of
these patients differed from age of patients with RF-related AVB (73±14 vs
56±17) (p< 0.04). 5 patients with transitory AVB3 remained symptomatic
with alternating slow junctional rhythm and sinus tachycardia. 
Conclusions: AVB remains frequent during AVNRT ablation (10%) but it
is frequently benign and not directly related to the RF application. Permanent
complete AVB is exceptional (0.2%). Patients with transitory complete AVB
remain at high risk of later events as conduction disturbances or sinus
tachycardia. Other AVB’s are age-related and probably without relation with
ablation. Permanent or transitory 1 degree AVB seems without clinical signi-
ficance. 
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Background: Little is known about predictors of high-degree atrioven-
tricular block (AVB) in patients without evidence of advanced His-Pur-
kinje conduction disturbances at electrophysiological study (EPS)
performed for unexplained syncope associated with bundle branch block
(BBB). 
Aims: Identify electrocardiographic predictors of high-degree AVB
during follow-up of these patients. Methods. In this multicenter cohort,
patients were included if they had: (1) unexplained syncope, (2) bundle
branch block (≥120ms), (3) no HPCD at EPS, i.e. baseline HV interval
<70ms, and absence of 2nd- or 3rd-degree AVB induced with atrial pacing
or ajmaline challenge. 
Results: Among the 150 studied patients (72±14 years, 62% male, mean
left ventricular ejection fraction 57±8%), index electrocardiograms showed
right BBB (70%; n=105), left BBB (2.7%; n=41), and nonspecific intraven-
tricular conduction disturbance (3%; n=4). A first-degree AVB was noted in
62 patients (44.3%). During a mean follow-up of 584±88 days, high-degree
AVB was documented in 25 patients (17%). The presence of a first-degree
AVB on the index electrocardiogram was associated with an increased risk
of subsequent high-degree AVB [72% vs. 35%; p<0.01]. Conversely, no
patients with isolated right BBB developed high-degree AVB after a normal
EPS. 
Conclusion: In patients with unexplained syncope associated with BBB,
16% of patients subsequently developed high-degree AVB despite no evi-
dence of advanced HPCD at EPS. This was more likely to occur in patients
with first-degree AVB at presentation. Conversely, this finding never occurred
in patients with isolated RBBB and normal PR interval. 
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Introduction: long QT and related ventricular arrhythmias may complicate
the evolution of Eating Disorders (ED) but duration of QT interval and pre-
valence of long QT in large series of ED patients has not been reported.
Methods: QT intervals were measured in 100 consecutive ED patients
(anorexia nervosa, bulimia nervosa or mixed) in lead II, V2 and V5 and
corrected using Bazett’s formula. 95 healthy subjects matched in age and
gender forms the control group. 
Results: mean age was 30±12 yo and 93% were females. Mean Body
Mass Index (BMI) was 16.9±3kg/m2. Heart rate was significantly lower in
patients with ED (64±14 bpm) compared to controls (78±15 bpm)
(p<0.0001).
QT were significantly longer in ED patients than in controls in leads II
(384±33 vs 366±32, p=0.0003), V2 (377±37 vs 367±35ms, p=0.04) and V5
(381±34 vs 365±30ms, p=0.0005). Corrected QT were significantly shorter in
patients with ED compared to controls in leads II (389±28 vs 412±28ms), V2
(383±27 vs 413±32ms) and V5 (387±26 vs 410±28ms) (p<0.0001 for each
comparison). None of the ED patients had a corrected QT >480 msec (max
